Purpose of the study is to determine the effect of the investigational products as consumed with a meal on serum lipids, primarily on LDL cholesterol.

Inclusion Criteria:

• male and female over 18 years old
• serum LDL cholesterol > 3.0 mmol/L
• BMI < 35
• subjects must voluntarily sign the informed consent

Exclusion Criteria:

• subjects using lipid lowering medication (ezetimibe, bile acid sequestrant, statin therapy)
• subjects with any hepatic or renal disorder according to medical history
• subjects who have history of myocardial infarction or unstable angina pectoris within six months prior to screening
• subjects who have history of coronary artery bypass graft or percutaneous transluminal coronary angioplasty within six months prior to screening
• subjects who have history of temporal ischemic attack or stroke within six months prior to screening
• subjects who have a history of cancer or other malignant disease within the past five years
• subjects who are consuming more than 15 portions of alcohol / week
• subjects who are pregnant or lactating
• subjects using cholesterol-lowering foods or dietary supplements within 14 days before start of the intervention
• subjects with intolerance to any ingredient of the test product